close icon

Ryman Stock Can Revisit Its Covid Crash Lows

Retirement homes were hit especially hard by COVID-19. Sadly, many of their clients lost their very lives as elderly people are the most vulnerable demographic. And although New Zealand and Australia have so far dealt with the pandemic better than most, the spring of 2020 was a real nightmare for companies like Ryman Healthcare.

With its 34 retirement villages in New Zealand, two in Melbourne and eight under construction in Victoria, Ryman is a large rest home operator. So when the coronavirus panic struck last year there was no way for the stock to escape the carnage. After trading above NZ$ 17 in February 2020, RYM was down 61% to NZ$ 6.61 at one point in March.

Fortunately for investors, most of those losses were erased almost as quickly as the gains before them. By November 2020, Ryman was hovering around NZ$ 16 again. As of this writing, however, the recovery seems to have gone out of steam. With the share price slightly over NZ$ 13.20, is this a dip to buy or the start of another big selloff?

Ryman Stock to Revisit its Covid Crash Lows

The weekly chart above visualizes Ryman ‘s entire history as a public company. It also reveals that the 20-year uptrend from the IPO until the top in 2019 has taken the shape of a textbook five-wave impulse. The pattern is labeled (1)-(2)-(3)-(4)-(5), where the five sub-waves of wave (5) are visible, as well.

Charts and Fundamentals Agree that Ryman Healthcare is Expensive

Ralph Nelson Elliott once discovered that a three-wave correction follows every impulse. Of course, we can never be sure what would’ve otherwise happened. However, this means Ryman stock was supposed to decline even without Covid-19. It was time for a retracement anyway.

The problem is that last year’s crash doesn’t look like a three-wave pattern. It looks more like a single wave (a) within a larger correction that is still in progress. If that assumption is correct, the following recovery to NZ$ 16.02 must be wave (b). This, in turn, suggests the current weakness is the beginning of wave (c).

C-waves usually breach the end of the corresponding wave A. In Ryman ‘s case, this translates into a decline below NZ$ 6.61. In our opinion, bearish targets in the NZ$ 6-5 area make sense as long as the stock trades below NZ$ 16.

Besides, Elliott Wave analysis is not the only reason we’re skeptical of Ryman stock. The company makes about NZ$ 150 million in free cash flow a year and has a market cap of NZ$ 6.5 billion. This gives us a P/FCF ratio higher than 43. Quite expensive for a company that is not growing that fast and has NZ$ 2.3 billion in debt.

In conclusion, fundamentals and charts seem to agree that NZ$ 13 a share is too high a price for Ryman Healthcare. The stock can revisit its Covid crash lows before the bulls return. We plan on watching from a safe distance.

Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!

Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

MongoDB – Bearish Pattern Joins Nosebleed Valuation

MongoDB Inc. is a general purpose database platform developer and provider. The company was founded in 2007, but only came public ten years later – in 2017. During the following four years, the stock has risen from an IPO price of $33 to $515 a share as of last week. So, it is fair to…

Read More »

Pandora Does Things Right. Stock May Need a Breather

When we wrote our previous article on Danish jewelry maker Pandora in December, 2020, the stock was up over three-fold since March. That recovery from DKK 180 to DKK 651 didn’t not come out of the blue, though. It was the result of a bullish setup we managed to identify as early as July 2019.…

Read More »

Match ‘s SP500 Inclusion a Good Excuse to Reach $200

Match Group Inc. rose over 10% in post-market trading Friday following reports that it is going to be included in the S&P 500. The company, which owns Tinder, OkCupid and most other major dating apps in the U.S., has a market cap of over $41B. Despite the anticipated “summer of love”, though, this is not…

Read More »

Cameco Stock Seems to Have Finally Turned a Corner

Uranium spot prices are on the verge of breaking above $34/lb, up over 80% from the bottom of $18/lb reached in late-2016. Cameco, as one of the world’s top uranium producers, is now seeing its stock price rising in tandem. Yesterday, it closed at $19.16 after reaching $21.95 in June. We first covered Cameco in…

Read More »

A Fresh Look At Cigna ‘s Elliott Wave Super Cycle

In a case study article on Cigna, published in October, 2016, we examined how a fundamentally sound and undervalued stock can still drop nearly 90%. The reason for that crash didn’t lie in some company specific issue. Rather it happened to occur during the biggest financial crisis in 80 years. Nevertheless, we made the point…

Read More »

CBOE Takeover Rumor Lifts Stock to Elliott Wave Target

We first wrote about CBOE Global Markets less than eight months ago. The S&P 500 had already recouped all its COVID selloff losses and was hovering at new all-time highs. CBOE, in contrast, was still down 30% from its 2018 record, trading below $97 a share. For some reason, the market was ignoring the company’s…

Read More »

Ahead of Ulta Beauty ‘s 150% Gain Since Lockdown

Buying shares in a beauty retailer in March 2020 sounded like a crazy, stupid idea. Stock markets around the world were plunging at a record pace amid a global GDP crash resulting from government-enforced lockdowns. People were stockpiling necessities in preparations not to leave their homes in the foreseeable future. With COVID-19 cases rising everywhere,…

Read More »

More analyses